Model Peptide Studies Demonstrate That Amphipathic Secondary Structures Can Be Recognized by the Chaperonin GroEL (cpn60)*

(Received for publication, August 30, 1996, and in revised form, October 25, 1996)

Bill T. Brazil Dagger , Jeffrey L. Cleland §, Robert S. McDowell §, Nicholas J. Skelton §, Ken Paris § and Paul M. Horowitz Dagger

From the Dagger  Department of Biochemistry, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284-7760 and § Genentech Inc., South San Francisco, California 94080

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

The molecular chaperone cpn60 binds many unfolded proteins and facilitates their proper folding. Synthetic peptides have been used to probe the question of how cpn60 might recognize such a diverse set of unfolded proteins. Three hybrid peptides were synthesized encompassing portions of the bee venom peptide, apamin, and the sequence KWLAESVRAGK from an amphipathic helix in the NH2-terminal region of bovine rhodanese. Two disulfides connecting cysteine residues hold the peptides in stable helical conformations with unobstructed faces oriented away from the disulfides. Peptides were designed to present either a hydrophobic or hydrophilic face of the amphipathic helix that is similar to the one near the amino terminus of rhodanese. Aggregation of these peptides was detected by measuring 1,1'-bis(4-anilino)napthalene-5,5'-disulfonic acid (bisANS) fluorescence at increasing peptide concentrations, and aggregation was not apparent below 2 µM. Thus, all experiments with the peptides were performed at a concentration of 1 µM. Reducing agents cause these helical peptides to form random coils. Fluorescence anisotropy measurements of fluorescein-labeled peptide with the exposed hydrophobic face yielded a Kd = ~106 µM for binding to cpn60, whereas there was no detectable binding of the reduced form. The peptide with the exposed hydrophilic face did not bind to cpn60 in either the oxidized or reduced states. Fluorescence experiments utilizing bisANS as a probe showed that binding of the helical hydrophobic peptide could induce the exposure of hydrophobic surfaces on cpn60, whereas the same peptide in its random coil form had no effect. Thus, binding to cpn60 is favored by a secondary structure that organizes and exposes a hydrophobic surface, a feature found in amphipathic helices. Further, the binding of a hydrophobic surface to cpn60 can induce further exposure of complementary surfaces on cpn60 complexes, thus amplifying interactions available for target proteins.


INTRODUCTION

It has been accepted for some time that the amino acid sequence of a protein contains all the information to specify its tertiary conformation (1). However, in vitro refolding is often inefficient due to competing kinetic pathways that lead to aggregation or the formation of non-native conformations (2). It is believed that aggregation is a result of the association of hydrophobic surfaces that are normally hidden in the core of a folded protein but are exposed in partially folded states. The yields of properly folded protein in these in vitro experiments can be improved by carefully selecting conditions such as lower temperature (3), lower protein concentration (4), or the addition of "nondenaturing" detergents (5), all of which favor folding. It is of interest to consider how aggregation can be avoided in vivo, where temperatures remain relatively constant and high local concentrations of interactive nascent polypeptides are often present.

Molecular chaperones are a group of cellular proteins known to be mediators of in vivo folding. Molecular chaperone proteins are mainly found in one of three highly conserved groups, Hsp60, Hsp70, and Hsp90, ranging from prokaryotes to mammals. Some molecular chaperones are expressed during heat shock, whereas others are expressed constitutively and are necessary for cell survival at nonstressed physiological conditions (6). A characteristic property of molecular chaperones is that they can bind non-native forms of proteins and release them in a controlled manner.

Escherichia coli Cpn60 (GroEL) is homologous to the eukaryotic mitochondrial protein Hsp60, and it is one of the best studied molecular chaperones. Cpn60 is composed of fourteen 57-kDa monomers assembled into two stacked seven-subunit rings (7). Cpn60 assists in vitro refolding of a number of proteins, e.g. rhodanese (8), citrate synthase (9), and lactate dehydrogenase (10). Unfolded rhodanese forms a binary complex with Cpn60 (8) that requires the addition of the co-chaperonin cpn10 (groES), MgATP, and K+ for the most efficient release of folded, active rhodanese (11).

The detailed mechanism for the binding and release of target proteins by cpn60 is incompletely understood. The fact that cpn60 can bind a wide variety of non-native polypeptides suggests that the molecular recognition is not specific for the sequence of the target. The 2.8 Å crystal structure and mutational analysis of cpn60 suggest that the polypeptide binding sites contain essential hydrophobic residues located in the apical domains of each cpn60 monomer (12, 13). The common feature shared by the proteins that bind cpn60 has been suggested to be the presence of hydrophobic surfaces on folding intermediates. It was proposed by Martin et al., for example, that dihydrofolate reductase and rhodanese are bound to cpn60 as "molten globule" intermediates (14).

It has been proposed that the secondary structure of regions of target proteins may be important for binding to cpn60 (15). For example, transferred nuclear Overhauser enhancement NMR experiments were used to study the binding of a peptide based on the NH2-terminal sequence of rhodanese. The binding was extremely weak (Kd = ~1000 µM), but the peptide, which was a random coil in solution, appeared when bound to adopt a helical conformation. It was conjectured that the sequence that could form an amphipathic helix might bind along the hydrophobic face. A second example, the capture of an all beta -sheet Fab fragment by cpn60 (16), indicates that the specific secondary structure is not the determinant for the recognition by cpn60.

To investigate the structural and chemical nature of cpn60-substrate interactions, we chose to study constrained peptides. Apamin is a peptide component of bee venom that contains 18 residues with two disulfide bonds bridging Cys1 to Cys11 and Cys3 to Cys15. These disulfides lock the COOH-terminal half of apamin (residues 9-16) into a helical conformation (18, 35). Various sequences can be substituted into the COOH terminus of apamin and forced into a helical conformation by the presence of these disulfide bridges (19).1 The apamin framework can be used to present either the hydrophobic or hydrophilic face of an amphipathic helix (17), and thus it serves as a useful tool for examining the structural requirements for binding to cpn60. Hybrid apamin peptides were constructed containing the NH2-terminal sequence of rhodanese (KWLAESVRAGK), which has been shown to bind in a helical conformation to cpn60. These peptides were then tested for their ability to bind cpn60. The peptides have the following sequences: C1NC3K(FITC)APETALC11WLAC15SVRAGK-NH2 (APA09), C1NC3KAPETALC11WLAC15SVRAGK-NH2 (APA14), and C1NC3K(FITC)APETKWC11AESC15RAGK-NH2 (APA08), with bold letters representing the rhodanese amino acids.2 The acronyms APA09 and APA14 are used in describing the hydrophobic peptides, and APA08 is used in describing the hydrophilic peptide. APA09 and APA08 were both synthesized with a FITC-labeled3 lysine at residue 4. Using these peptides, we demonstrate that an amphipathic alpha -helix with hydrophobic residues on its exposed helical face can bind to cpn60, and this binding can lead to exposure of hydrophobic surfaces buried within cpn60.


EXPERIMENTAL PROCEDURES

Reagents and Proteins

All reagents were analytical grade. 1,1'-Bis(4-anilino)napthalene-5,5'-disulfonic acid (bisANS) was obtained from Molecular Probes (Junction City, OR). The chaperonin, cpn60, was purified from lysates of cells containing the multicopy plasmid pGroESL (20). Following purification, cpn60 was dialyzed against 50 mM Tris-HCl, pH 7.5, containing 1 mM DTT. Then glycerol was added to 10% (v/v), and aliquots were frozen in liquid nitrogen and stored at -80 °C. The monomer concentration of cpn60 was measured at 280 nm with an extinction coefficient of 1.22 × 107 M-1 cm-1 as determined by quantitative amino acid analysis, assuming a molar mass of 60 kDa (21).

Preparation of Peptides

The peptides were synthesized on para-methyl benzhydrylamine resin utilizing t-butoxycarbonyl chemistry with rapid manual cycles as described previously (22). The peptides were prepared with t-butoxycarbonyl-Lys (epsilon  Fmoc) in the lysine 4 position. The Fmoc was removed with 20% piperidine in DMA after stepwise synthesis and prior to hydrogen fluoride cleavage. Fluorescein was incorporated into APA08 and APA09 by the addition of 4-fold excess FITC and diisopropylethylamine in DMA. The final t-butoxycarbonyl group was removed, the peptides were cleaved from the resin, and the side chain protecting groups were removed by treatment with anhydrous liquid hydrogen fluoride at 0 °C for 1 h (10 ml of hydrogen fluoride, 1.0 ml of anisole, 0.2 ml of ethyl methylsulfide, 0.1 ml of thioanisole, 0.1 g of para-thiocresol/g of resin). The resultant peptide/resin mixture was washed with diethyl ether and extracted with 20% acetic acid. The crude linear peptide was lyophilized and purified by C18 reverse phase HPLC, eluting with a 23-38% acetonitrile gradient. The purified linear peptide was cyclized by dissolving it in water at a concentration of 0.1 mg/ml, adjusting the pH to 8.0-8.5 with ammonium hydroxide and stirring at 20 °C for 3 days. The pH was then adjusted to 3.0 with acetic acid, and the solution was either lyophilized or maintained as the 0.1 mg/ml acidified solution and submitted for HPLC purification. The identity of each peptide was characterized by amino acid sequencing and mass spectroscopy.

Peptide Sequences

The hydrophilic peptide APA08 has the sequence CNCK(FITC)APETKWCAESCRAGK-NH2. The hydrophobic peptides APA09 and APA14 have the sequences CNCK(FITC)APETALCWLACSVRAGK-NH2 and CNCKAPETALCWLACSVRAGK-NH2, respectively. The bold characters in the above sequences represent the NH2-terminal portions of bovine rhodanese inserted into the apamin peptide. Disulfide bonds form between cysteine residues 1 and 11 and between cysteine residues 3 and 15 in the oxidized form of each peptide. The cyclized (oxidized) peptides are designated as APA08c, APA09c, and APA14c, with the lowercase c denoting the peptides in the cyclized form. The linear (reduced) peptides are designated as APA08r, APA09r and APA14r, with the lowercase r denoting the peptides in the reduced form.

Circular Dichroism Measurements

Each peptide was reconstituted in 20 mM sodium acetate, pH 5.5, and placed in a 0.05-cm pathlength quartz cell. All samples were filtered. The final concentrations were determined by absorbance measurements. The concentrations of each peptide were as follows: 0.165 mg/ml for APA08 cyclized, 0.020 and 0.031 mg/ml for APA09 linear and cyclized, respectively, and 0.30 mg/ml for APA14 linear and cyclized. The samples were analyzed with an Aviv Circular Dichroism Spectrometer (model DS/60, Aviv Associates, New York, NY) using a constant bandwidth of 1.0 nm. Spectra were taken from 190 to 250 nm at 0.2-nm intervals with an averaging time of 3.0 s/data point. All spectra were acquired in triplicate and averaged. The spectrum of an appropriate buffer control sample was then subtracted from each of the sample spectra. The final spectral data were converted to mean residue weight ellipticities for determination of secondary structure content (mean residue weight factors: APA08, 129.9; APA09, 124.1; and APA14, 105.6). The mean residue weight ellipticities were used to calculate the relative contribution of secondary structural components (alpha -helix and beta -sheet) to the overall spectra. The spectral deconvolution method utilized for these calculations has been described previously (23).

NMR

The peptide APA14 (2.0 mg) was dissolved in 440 µl of 95% H2O/5% D2O, and the pH was adjusted to 4.6 by microliter additions of 1 M NaOH; 50 µl of CD3CN (final concentration, 1.9 M) was added to improve solubility. All spectra were acquired at 25 °C on a Bruker AMX-500 spectrometer. Two-dimensional phase sensitive correlation spectroscopy (24), NOE spectroscopy (25-27), jump-return NOE spectroscopy (28), and total correlation spectroscopy (29, 30) spectra were acquired with low power coherent irradiation of the water resonance for 1.5 s prior to the pulse sequence and during the NOE spectroscopy mixing time. Total correlation spectroscopy mixing was achieved with a clean DIPSI-2rc sequence applied for 90 ms (31), and mixing times of 300 ms were used in both NOE spectroscopy experiments. The spectra were processed and analyzed using Felix (Biosym Technologies, San Diego, CA), and assigned using established techniques (32). 3JHN-Halpha were obtained by line fitting omega 2 slices from the correlation spectroscopy spectrum processed with very high digital resolution. A second set of NMR spectra were acquired after the addition of 10 µl of 2 M DTT to allow the uncyclized (reduced) peptide to be studied. A rotating frame Overhauser spectroscopy spectrum (33) of the uncyclized peptide failed to identify any additional dipolar coupling interaction.

Fluorescence Spectroscopy

Fluorescence of bisANS was measured using an excitation wavelength of 397 nm and an emission wavelength of 500 nm. Anisotropy measurements on APA08 and APA09 peptides, each of which had Lys4 labeled with fluorescein, were performed with an excitation wavelength of 492 nm and emission wavelength at 519 nm. Fluorescence studies were carried out on a SLM model 500C fluorometer with an excitation slit width of 2.5 nm and emission slit width of 10 nm.

Peptide Binding Measurements

Binding experiments were carried out on both APA08 and APA09 peptides in the oxidized and reduced states as follows. To a cuvette containing 50 mM Tris-HCl, pH 7.8, a given peptide was added to a concentration of 1 µM, and the anisotropy values were recorded at 20 °C. To this solution, cpn60 that had been dialyzed against 50 mM Tris-HCl, pH 7.8, was added to the cuvette to a final concentration of 10 µM, and the anisotropy value was measured.

A dissociation constant was estimated for oxidized APA09, which was the only fluorescently labeled peptide that displayed detectable binding to cpn60. The approach used was to titrate a 1 µM solution of the oxidized APA09 peptide with increasing amounts of cpn60. Titrations using increasing peptide concentrations were not possible because of strong self-association, as expected with amphipathic structures and demonstrated with these peptides (see "Results"). The dissociation constant was estimated as follows:
<UP>Cpn</UP>60−<UP>APA</UP>09↔<UP>Cpn</UP>60+<UP>APA</UP>09; K<SUB>d</SUB>=<FR><NU>[<UP>C</UP>][<UP>F</UP>]</NU><DE>[<UP>C<SUB>F</SUB></UP>]</DE></FR> (Eq. 1)
where [CF], [C], and [F] are the concentrations of binary complexes cpn60-APA09, cpn60, and APA09, respectively. If only the fluorophore-protein complexes ([CF]) result in significant anisotropy (r), then at a fixed total concentration of fluorophore ([FT]) and increasing concentrations of protein ([CT]), the anisotropy of bound (rbound) can be determined from a plot of [1/r] versus [1/[CT]], in which the y intercept is [1/rbound].
r<SUB><UP>obs</UP></SUB>=f<SUB><UP>B</UP></SUB>r<SUB><UP>B</UP></SUB>+f<SUB><UP>F</UP></SUB>r<SUB><UP>F</UP></SUB> (Eq. 2)

In Equation 2, robs is the measured anisotropy at a given protein concentration, fB and fF are the fractions of fluorophore bound and free, respectively, and rB and rF are the anisotropy values when the fluorophore is all bound or all free, respectively. Because rfree is small, Equation 2 can be simplified to:
r<SUB><UP>obs</UP></SUB>=f<SUB><UP>B</UP></SUB>r<SUB><UP>B</UP></SUB> (Eq. 3)
or
f<SUB><UP>B</UP></SUB>=<FR><NU>r<SUB><UP>obs</UP></SUB></NU><DE>r<SUB><UP>max</UP></SUB></DE></FR> (Eq. 4)
Thus, at any given protein concentration, assuming one binding site per monomer, the fraction of fluorophore bound can be determined using Equation 4.
[<UP>C<SUB>F</SUB></UP>]=f<SUB><UP>B</UP></SUB>[<UP>F<SUB>T</SUB></UP>] (Eq. 5)
[<UP>F</UP>]=[<UP>F<SUB>T</SUB></UP>]−[<UP>C<SUB>F</SUB></UP>] (Eq. 6)
[<UP>C</UP>]=[<UP>C<SUB>T</SUB></UP>]−[<UP>C<SUB>F</SUB></UP>] (Eq. 7)
[<UP>C<SUB>F</SUB></UP>]=[<UP>C</UP>][<UP>F</UP>]<FENCE><FR><NU>1</NU><DE>K<SUB>d</SUB></DE></FR></FENCE> (Eq. 8)
Plotting Equation 8 as [CF] versus [C][F], the slope of the fitted line is [1/Kd].

bisANS Binding Experiments

To follow hydrophobic exposure on cpn60, 10 µM bisANS was added to a cuvette containing 1 µM cpn60, and the emission spectrum was recorded. Subsequently, 1 µM oxidized APA14 was added to the cuvette, and the bisANS emission was recorded. BisANS fluorescence was insignificant in the presence of 1 µM oxidized APA14 alone (data not shown). The increase in bisANS fluorescence in the presence of cpn60 was attributed to hydrophobic exposure induced on the chaperonin by the oxidized APA14 peptide. To follow loss of hydrophobic sites following reduction of the peptide, 2 mM DTT was added to the samples above. Emission spectra were collected from 0 to 40 min.


RESULTS

Apamin Hybrid Peptide Structural Characterization

The CD spectra of the oxidized peptides, APA09c (Figs. 1A), APA14c (Fig. 1B), and APA08c (Fig. 1C), indicate a high degree of helical secondary structure, whereas the spectra of reduced peptides, APA09r (Fig. 1A) and APA14r (Fig. 1B), indicate there is little or no regular helical structure. The secondary structure calculated for each peptide in either the oxidized or reduced form is shown in Table I. The fluorescein-labeled peptides APA08 and APA09 were not soluble at concentrations required for NMR. However, analysis of oxidized APA14c by 1H NMR spectroscopy identified intense HN-HN sequential NOEs and medium range NOEs characteristic of a helix between residues 9 and 16 (Fig. 2); the presence of a helical conformation is confirmed by the small values of 3JHN-Halpha for these residues. The data for residues 17-19 are not indicative of a well formed helix, suggesting that they form a frayed terminus to the helix or adopt a turn conformation. These findings are in line with the structure modeled for APA14 and are consistent with the three-dimensional structures determined for other apamin peptides (35).1 Many of the chemical shifts of oxidized APA14c are found to be very different from random coil values, suggesting that the peptide does adopt a well defined structure. The addition of dithiothreitol to the peptide resulted in a loss of the characteristic helical NOEs, an increase in the 3JHN-Halpha scalar coupling constants (Fig. 2, lower panel), and movement of the resonances to approximately random coil positions. Helical interactions were also absent from rotating frame Overhauser spectroscopy spectra, indicating that the loss of NOE intensity was not the result of a change in rotational correlation time. Thus, the disulfide bonds are required to maintain APA14 in a helical conformation. The predicted structure of these peptides is shown in Fig. 3, and the surface hydrophobicity of each peptide is also presented.


Fig. 1. The far ultraviolet circular dichroism spectra of the rhodanese amino-terminal apamin peptides. A, APA09 cyclized (solid line) and linear (dotted line). B, APA14 cyclized (solid line) and linear (dotted line). C, APA08 cyclized (solid line).
[View Larger Version of this Image (15K GIF file)]


Table I.

Secondary structure of apamin peptides


Peptide Fractionsa
 alpha -Helix  beta -Sheet Remainder

APA08c 0.55  ± 0.012 0.45  ± 0.012 0.0  ± 0.0
APA09r 0.19  ± 0.019 0.81  ± 0.019 0.0  ± 0.0
APA09c 0.71  ± 0.013 0.29  ± 0.013 0.0  ± 0.0
APA14r 0.0  ± 0.0 0.46  ± 0.008 0.54  ± 0.008
APA14c 0.57  ± 0.014 0.27  ± 0.027 0.16  ± 0.039

a  Far ultraviolet circular dichroism spectra from Fig. 1 were deconvoluted as previously described (23).


Fig. 2. NOE and 3JHN-Halpha data for APA14 in the cyclized and uncyclized form. For the dNN, dbeta N, and dalpha N rows, observation of a sequential NOE is indicated by a bar between two residues; the thickness of the bar indicates the relative intensity of the NOE. The downward pointing arrows and vertical bars indicate 3JHN-Halpha less than 6.0 Hz or between 6.0 and 8.0 Hz, respectively. Observed medium range NOEs (dalpha N(i,i+3), dalpha N(i,i+3), and dalpha N(i,i+4)) are indicated by the thin lines in the lower part of each panel. The helical motif above the primary sequence indicates the region deduced to have helical structure in the cyclized form; the broken coil indicates that the COOH terminus of the helix is frayed. The lines above the primary sequence indicate the disulfide bonds present in the cyclized form. Asterisks indicate data missing because of chemical shift degeneracy. In the uncyclized form, sequential dbeta N NOEs were very weak or nonexistent, and no medium range NOEs were observed.
[View Larger Version of this Image (39K GIF file)]



Fig. 3. Models of APA08 and APA09, respectively, based on the NMR structure of Apamin (38). The backbone of the peptide is shown in gray, with the side chains substituted from rhodanese in cyan. Cysteines are indicated in orange. Side chain conformations are taken from the crystal structure of rhodanese (39). C and D, solvent-accessible surfaces of the exposed helices represented in A and B. These surfaces are colored according to an effective "hydrophobic potential" derived from the desolvation parameters of Eisenberg et al. (34), in which exposed hydrophilic regions are indicated in red, and exposed hydrophobic regions are indicated in blue.4
[View Larger Version of this Image (119K GIF file)]


Low Peptide Concentrations Are Critical to Avoid Aggregation

Oxidized APA09c and APA14c are amphipathic helical peptides with exposed hydrophobic faces. Thus, the question of solubility and formation of aggregates was addressed. BisANS fluorescence was used to detect aggregation of oxidized APA14c (Fig. 4) and reduced APA14r (data not shown). A cuvette containing 10 µM bisANS was titrated with increasing amounts of either oxidized APA14c or reduced APA14r. There was relatively little increase in bisANS fluorescence in the range of peptide concentrations from 0 to 2.0 µM, but there was a substantial increase that occurred above 2 µM APA14. As shown in Fig. 4B, the fluorescence response is reminiscent of similar titrations that are used to define the critical micelle concentrations of amphiphilic detergents (36). Thus, significant self-association of the peptide occurs when its concentration is higher than 2-3 µM. To avoid artifacts and interpretive complications from aggregation, all experiments with APA08, APA09 (the fluorescein-labeled form of APA14), and APA14 were done at a concentration of 1 µM.


Fig. 4. Fluorescence of bisANS at increasing concentrations of oxidized APA14. A, spectra. Oxidized APA14 was titrated into a cuvette containing 10 µM bisANS. The spectra from bottom to top represent oxidized APA14 concentrations of 0, 0.5, 0.8, 2.0, 3.9, 5.7, and 7.4 µM, respectively. Excitation of bisANS was performed at 397 nm, and emission was detected at 500 nm at 20 °C. The bisANS fluorescence spectra blue shift as the concentration of oxidized APA14 increases. B, fluorescence intensity of bisANS versus [APA14c]. Maximum fluorescence intensities of spectra shown in A are plotted as a function of the APA14c peptide concentration.
[View Larger Version of this Image (18K GIF file)]


Binding of Oxidized and Reduced APA09 to cpn60 Can Be Measured by Fluorescence Anisotropy

Fluorescence anisotropy binding studies were done using the fluorescein-labeled APA09 peptides (same sequence as APA14). Initial experiments were done to determine any differences in the binding affinity of oxidized APA09c and reduced APA09r.

The anisotropy of 1 µM APA09c free in solution had a value of 0.061 ± 0.004. The anisotropy of 1 µM APA09c in the presence of 10 µM cpn60 was 0.084 ± 0.003. On the other hand, there was virtually no change in the anisotropy of free APA09r (0.055 ± 0.008) as compared with APA09r in the presence of cpn60 (0.050 ± 0.006). The dissociation constant for oxidized APA09c was determined as described under "Experimental Procedures." Cpn60 was titrated into a solution of 1 µM oxidized APA09c over a concentration range of 1-65 µM cpn60. The inverse of the change in anisotropy was plotted as a function of the inverse of the cpn60 monomer concentration, and the data were fit with a straight line (Fig. 5B). The anisotropy of bound peptide was determined from the y-intercept of the straight line as explained under "Experimental Procedures." The concentration of cpn60/APA09c complex formed was then plotted against the concentration of free cpn60 multiplied by the concentration of free APA09c (Fig. 5). The data were fit to a straight line, and by taking the inverse of the slope, a Kd was estimated to be approximately 106 (± 6) µM. Independent of the assumptions used for the analysis of these data, it is clear that the oxidized peptide shows considerable binding, whereas the reduced version of the same peptide shows no detectable interaction. The oxidized APA08c peptide was subjected to the same fluorescence anisotropy experimental conditions, and no change in anisotropy was detected. Thus, the oxidized APA08c hydrophilic peptide did not bind to cpn60 as observed by fluorescence anisotropy measurements.


Fig. 5. Determination of the dissociation constant for oxidized APA09. A, as described under "Experimental Procedures," Equations 1-8 were used to determine the Kd of APA09c. The concentration of fluorophore, APA09c, was held constant at 1 µM, whereas cpn60 was titrated into the cuvette containing APA09c. A plot of [CF] versus [C][F] was fit to a straight line according to Equation 8, with the inverse of the slope being equal to the Kd. A straight line was fitted to the data points, and from the slope of this line the Kd was determined. Panel B shows the data used to determine the anisotropy of bound APA09c as described in the text.
[View Larger Version of this Image (11K GIF file)]


Oxidized APA14 Induces Hydrophobic Exposure on cpn60

Changes in bisANS fluorescence were used to assess changes in hydrophobic exposure in solutions containing cpn60 together with APA14c. When 10 µM bisANS was mixed with 1 µM cpn60, the maximum fluorescence intensity was observed at 502 nm. When 1 µM oxidized APA14c was added, the maximum fluorescence intensity increased by a factor of 1.7 with no change in the wavelength maximum. Fig. 6 shows the time course of the bisANS fluorescence intensity after the addition of 2 mM DTT to the APA14c-cpn60 mixture. The decrease in bisANS fluorescence that followed the reduction of the peptide could be modeled by a single exponential with a decay rate constant = 0.065/min (Fig. 6). A control sample showed that the fluorescence intensity of 10 µM bisANS did not change upon the addition of 2 mM DTT. These results indicate that the complex of cpn60 with APA14c displays considerably more hydrophobic exposure than the sum of the individual components, and the result requires the presence of the oxidized and not the reduced peptide.


Fig. 6. Time dependence of bisANS fluorescence after addition of DTT. The percentage of change in bisANS fluorescence as a function of time after DTT addition to the APA14-Cpn60 complex. The data were fit to a single exponential equation. The first order constant describing the decrease of the bisANS fluorescence was 0.065 min-1.
[View Larger Version of this Image (8K GIF file)]



DISCUSSION

Cpn60 can bind a wide variety of proteins in non-native states, implying that the specific primary sequence does not supply the information required for recognition (9, 11, 14, 37). Because cpn60 does not bind proteins in their native folded state, the recognition does not require formation of native tertiary structure (14). The binding of various proteins must occur by a more general mechanism of molecular recognition. One common feature of partially folded proteins is the solvent exposure of hydrophobic residues that would be buried in the native state. As proteins fold, local regions can form secondary structures such as alpha  helices that can align residues to produce hydrophobic surfaces. These surfaces could provide the necessary binding motif for recognition by the cpn60 hydrophobic binding sites.

The oxidized peptides APA09c, APA14c, and APA08c used in this study address the issue of secondary structural requirements for binding to cpn60 and suggest a possible mechanism of cpn60 binding to unfolded proteins via induced hydrophobic exposure on cpn60 as a result of an initial amphipathic peptide binding.

The small size of APA09 compared with that of the cpn60 tetradecamer (798 kDa) allowed the binding of the peptide to cpn60 to be followed by fluorescence anisotropy. Oxidized APA09c was determined to bind weakly to cpn60 with a Kd = ~106 µM, assuming one binding site on cpn60. No binding of reduced APA09r was detected under the same experimental conditions. This result shows the effect of organizing the hydrophobic surface onto a helical motif. Although the binding interactions of these small peptides are weak, they should be viewed as a part of the many weak interactions that would occur with a partially folded protein containing numerous elements of local secondary structure. This implied multiple binding of a protein to the oligomeric cpn60 is supported by the previous observation that cpn60 quaternary structure is stabilized by interactions with partially folded proteins (38). That the hydrophilic peptide, APA08, shows no binding to cpn60 supports the suggestion that hydrophobic interactions are important in forming the cpn60-protein complex. These results are complementary to the data from Fenton et al. (13), where polypeptide binding studies were performed on various mutants of cpn60 to demonstrate the requirement for hydrophobic residues on cpn60 to bind partially folded proteins.

The present studies suggest that initial binding of amphipathic elements to cpn60 can induce the formation of increased hydrophobic exposure. When the interactions with the peptides are eliminated by reduction, the induced hydrophobic surfaces are lost. This may be related to the effects seen with proteins whose exposed, interactive surfaces are buried as they fold with two consequences: (a) they are bound less tightly to cpn60, and (b) the interactive surfaces on cpn60 are hidden and protected against nonproductive interactions.

The 2.8 Å crystal structure of cpn60 (12) as well as mutational analysis (13) have suggested that the polypeptide binding site on cpn60 resides in hydrophobic sequence within the apical domain of each monomer. The crystal structure in this region has poor resolution, presumably due to flexibility or malleability in this area of the apical domain (12). It is tempting to speculate that interactions with amphipathic structural elements could modify the exposure in this part of the structure and interactions with nucleotides or the co-chaperonins could modulate the interactions. Thus, organized amphipathic structures on unfolded proteins may not only be a part of the general recognition motif for cpn60 binding, but they may also serve as a means of amplifying the hydrophobic surface exposed by cpn60. Finally, the observed strong net binding to cpn60 of partially folded proteins may result from multiple weak interactions stemming from the symmetrical association of many subunits. This would allow some flexibility of the bound protein by dissociation at some of the sites without permitting its release from the complex.


FOOTNOTES

*   This research was supported by Research Grants GM25177 and ES05729 from the National Institutes of Health and Welch Grant AQ 723 (to P. M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
   To whom correspondence should be addressed: Dept. of Biochemistry, University of Texas Health Science Center, 7703 Floyd Curl Dr., San Antonio, TX 78284-7760. Tel.: 210-567-3737; Fax: 210-567-6595.
1    N. J. Skelton, unpublished data.
2    The cyclized (helical) apamin-rhodanese hybrid peptides are designated as APA08c, APA09c, and APA14c, with the lower case c denoting the cyclized peptide form. The linear (reduced) apamin-rhodanese hybrid peptides are designated as APA08r, APA09r, and APA14r, with the lower case r denoting the linear form.
3    The abbreviations used are: FITC, fluorescein isothiocyanate; DTT, Dithiothreitol; bisANS, 1,1'-bis(4-anilino)napthalene-5,5'-disulfonic acid; NOE, nuclear Overhauser effect; HPLC, high pressure liquid chromatography.
4    R. S. McDowell, unpublished data.

REFERENCES

  1. Anfinsen, C. B. (1973) Science 181, 223-230 [Medline] [Order article via Infotrieve]
  2. Fisher, G., and Schmid, F. X. (1990) Biochemistry 29, 2205-2212 [Medline] [Order article via Infotrieve]
  3. Viitanen, P. V., Lubben, T. H., Reed, J., Goloubinoff, P., O'Keefe, D. P., and Lorimer, G. H. (1990) Biochemistry 29, 5665-5671 [Medline] [Order article via Infotrieve]
  4. Horowitz, P., and Criscimagna, N. L (1986) J. Biol. Chem. 261, 15652-15658 [Abstract/Free Full Text]
  5. Tandon, S., and Horowitz, P. M. (1986) J. Biol. Chem. 261, 15615-15618 [Abstract/Free Full Text]
  6. Gething, M. J., and Sambrook, J. (1992) Nature 355, 33-45 [CrossRef][Medline] [Order article via Infotrieve]
  7. Hendrix, R. J. (1979) J. Mol. Biol. 129, 375-392 [Medline] [Order article via Infotrieve]
  8. Mendoza, J. A., Butler, M. C., and Horowitz, P. M. (1992) J. Biol. Chem. 267, 24648-24654 [Abstract/Free Full Text]
  9. Buchner, J., Schmidt, M., Fuchs, M., Jaenicke, R., Rudolph, R., Schmid, F. X., and Kiefhaber, T. (1991) Biochemistry 30, 1586-1591 [Medline] [Order article via Infotrieve]
  10. Badcoe, I. G., Smith, C. J., Wood, S., Halsall, D. J., Holbrook, J. J., Lund, P., and Clark, A. R. (1991) Biochemistry 30, 9195-9200 [Medline] [Order article via Infotrieve]
  11. Mendoza, J. A., Rogers, E., Lorimer, G. H., and Horowitz, P. M. (1991) J. Biol. Chem. 266, 13044-13049 [Abstract/Free Full Text]
  12. Braig, K., Otwinowski, Z., Hedge, R., Boisvert, D. C., Joachimiak, A., Horwich, A. L., and Sigler, P. B. (1994) Nature 371, 578-586 [CrossRef][Medline] [Order article via Infotrieve]
  13. Fenton, W. A., Yechezkel, K., Furtak, K., and Horwich, A. L. (1994) Nature 371, 614-619 [CrossRef][Medline] [Order article via Infotrieve]
  14. Martin, J., Langer, T., Boteva, R., Schramel, A., Horwich, A. L., and Hartl, F. U. (1991) Nature 352, 36-42 [CrossRef][Medline] [Order article via Infotrieve]
  15. Landry, S. J., and Gierasch, L. M. (1991) Biochemistry 30, 7359-7362 [Medline] [Order article via Infotrieve]
  16. Schmidt, M., and Buchner, J. (1992) J. Biol. Chem. 267, 16829-16833 [Abstract/Free Full Text]
  17. Wemmer, D., and Kallenbach, N. R. (1983) Biochemistry 22, 1901-1906 [Medline] [Order article via Infotrieve]
  18. Callewaert, G. L., and Shipolini, R. (1968) FEBS Lett. 1, 111-113 [CrossRef][Medline] [Order article via Infotrieve]
  19. Pease, J. H. B., Storrs, R. W., and Wemmer, D. E. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 5643-5647 [Abstract]
  20. Goloubinoff, P., Gatenby, A. A., and Lorimer, G. H. (1989) Nature 337, 44-47 [CrossRef][Medline] [Order article via Infotrieve]
  21. Fisher, M. T. (1992) Biochemistry 31, 3955-3963 [Medline] [Order article via Infotrieve]
  22. Scholzer, M., Alenwood, P., Jones, A., Alenwood, D., and Kent, S. B. (1992) Int. J. Pept. Protein Res. 40, 180-193 [Medline] [Order article via Infotrieve]
  23. Provencher, S. W., and Glockner, J. (1981) Biochemistry 20, 33-37 [Medline] [Order article via Infotrieve]
  24. Aue, W. P., Bartholdi, E., and Ernst, R. R. (1975) J. Chem. Phys. 64, 2229-2246
  25. Bodenhausen, G., Kogler, H., and Ernst, R. R. (1984) J. Magn. Reson. 58, 370-388
  26. Kumar, A., Ernst, R. R., and Wüthrich, K. (1980) Biochem. Biophys. Res. Commun. 95, 1-6 [Medline] [Order article via Infotrieve]
  27. Akke, M., Skelton, N. J., Kördel, J., and Chazin, W. J. (1991) in Techniques in Protein Chemistry II (Villafranca, J. J., ed), pp. 401-408, Academic Press, Boca Raton, FL
  28. Plateau, P., and Guéron, M. (1982) J. Am. Chem. Soc. 104, 7310-7311
  29. Braunschweiler, L., and Ernst, R. R. (1983) J. Magn. Reson. 53, 521-528
  30. Bax, A., and Davis, D. G. (1985) J. Magn. Reson. 65, 355-360
  31. Cavanagh, J., and Rance, M. (1992) J. Magn. Reson. 96, 670-678
  32. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids, John Wiley & Sons, Inc., New York
  33. Bothner-By, A. A., Stephens, R. L., Lee, J.-M., Warren, C. D., and Jeanloz, R. W. (1984) J. Am. Chem. Soc. 106, 811-813
  34. Eisenberg, D., Wesson, M., and Yamashita, M. (1989) Chem. Scr. 29A, 217-221
  35. Pease, J. H. B., and Wemmer, D. E. (1988) Biochemistry 27, 8491-8498 [Medline] [Order article via Infotrieve]
  36. Horowitz, P. M. (1977) J. Colloid and Interface Sci. 61, 197-198
  37. Liminet, A. A., Ziegelhoffer, T., Georgopopoulos, C., and Pluckthun, A. (1990) EMBO J. 99, 2315-2319
  38. Mendoza, J. A., and Horowitz, P. M. (1994) J. Biol. Chem. 269, 25963-25965 [Abstract/Free Full Text]
  39. Ploegman, J. H., Drent, G., Kalk, K. H., and Hol, W. G. J. (1978) J. Mol. Biol. 123, 557-594 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.